Code | 2012B | ||||||||||
MA number | EU/1/96/007/041 | ||||||||||
Product Form: | sol inj 5x3 ml (skl.nap. v napl.pere) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Eli Lilly Nederland B.V., Netherland | ||||||||||
Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 31.01.2008 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 18.06.2018 |